Chemoinformaics analysis of 5-HYDROXY-2-(2-PHENYLETHYL)CHROMEN-4-ONE
| Molecular Weight | 266.296 | nRot | 3 |
| Heavy Atom Molecular Weight | 252.184 | nRig | 18 |
| Exact Molecular Weight | 266.094 | nRing | 3 |
| Solubility: LogS | -3.425 | nHRing | 1 |
| Solubility: LogP | 3.805 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 17 |
| nHA | 3 | APOL | 40.1311 |
| nHD | 1 | BPOL | 16.6489 |
| QED | 0.791 |
| Synth | 2.068 |
| Natural Product Likeliness | 0.929 |
| NR-PPAR-gamma | 0.961 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.15 |
| Pgp-sub | 0.09 |
| HIA | 0.012 |
| CACO-2 | -4.854 |
| MDCK | 0.0000151 |
| BBB | 0.157 |
| PPB | 0.986558 |
| VDSS | 0.69 |
| FU | 0.0123748 |
| CYP1A2-inh | 0.988 |
| CYP1A2-sub | 0.824 |
| CYP2c19-inh | 0.968 |
| CYP2c19-sub | 0.094 |
| CYP2c9-inh | 0.905 |
| CYP2c9-sub | 0.953 |
| CYP2d6-inh | 0.642 |
| CYP2d6-sub | 0.866 |
| CYP3a4-inh | 0.443 |
| CYP3a4-sub | 0.279 |
| CL | 3.792 |
| T12 | 0.567 |
| hERG | 0.098 |
| Ames | 0.72 |
| ROA | 0.205 |
| SkinSen | 0.928 |
| Carcinogencity | 0.631 |
| EI | 0.968 |
| Respiratory | 0.15 |
| NR-Aromatase | 0.706 |
| Antiviral | Yes |
| Prediction | 0.745729 |